Family · Pharmaceutical analytical standards
Teneligliptin
A DPP-4 inhibitor (gliptin) for type 2 diabetes, developed in Japan and launched there in 2012; it has also been approved in Korea, India and Argentina. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.
Did you know?It has a J-shaped structure with five rings, described as an anchor-lock domain: a shape that hooks firmly onto the DPP-4 enzyme and blocks it strongly.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
